Simon Campion: Yes. Thanks for the question, Michael. We value the partnership that we have with our distributors. They have different degrees of meaningfulness to our organization in different regions, certainly in the US they’re very meaningful, and we have begun to build, I think, constructive relationships with them. But there are certain areas, of course, where we have a direct presence, such as implants and aligners. And we do tend to see great growth from those areas. So while we have constructive and developing relationships with our distributors, it is a unique environment within that — within dental, where your partners and competitors at the same time. So we are driving transparency with respect to our thought process with our — with those distributors in the US in particular.
Michael Cherny: Got it. That’s good for me. Thank you.
Operator: Thank you. One moment for our next question. And it comes from the line of Justin Lin with William Blair. Please proceed.
Justin Lin: Hi. Good morning. You mentioned you had a record quarter for SureSmile. I guess, in your view, what’s driving the success beyond improving macro? And are you more so taking share or expanding the market?
Glenn Coleman: Yes. So it was a record month in January, not quarter. So I just want to be clear, January was a really strong month. But obviously, the momentum around SureSmile continues. We still think it’s a very much underpenetrated market. Aesthetics are here to stay. So those are positive dynamics. But for us, SureSmile has fewer revisions from a clinical perspective, we’re seeing high customer engagement and geographic expansion, and all of that is leading to market share gains for us. So, we had a really robust 2022 year, and we expect that will continue to see good growth, both in SureSmile and Byte in 2023.
Justin Lin: Got you. And I guess that kind of leads me to my next follow-up question, if you may. I guess more longer-term question around your Clear Aligner strategy. How do you make a more meaningful push into the Ortho channel, if that’s part of your plan at all with sort of the other portion of the business being sort of direct-to-consumer.
Simon Campion: Yes. So Byte has performed very well for us over the past two quarters. We’ve had a lot of questions on Byte and the acquisition since we joined here last September. I think, it is synergistic with our SureSmile business. It has performed very well since we’ve arrived here. We have had great customer satisfaction scores through the My Byte app, which is really resonating with them, and it’s performing well. So, we see it as a as a meaningful part of our portfolio, one that we’re being diligent around expenses on and investing appropriately and driving customer acquisition, customer conversion and trying to increase customer satisfaction scores and drive the web traffic in that manner.
Glenn Coleman: Yes, I would just add, I mentioned this in some previous discussions. Obviously, with Ortho doing much better on a top line, a big part of our margin expansion and improvement story is around the bottom line as well. And our Ortho businesses are becoming more profitable, both in SureSmile and in Byte. So that’s also very encouraging relative to how we think about 2024, 2025, getting to higher operating margins, the EBITDA margins, our Ortho business should be a contributor to that and should be a nice tailwind when we go into 2024 for sure. Thanks for the question.
Justin Lin: Thank you.
Operator: And our last question, one moment please. And it comes from the line of Rachel Vatnsdal with JPMorgan Chase. Please go ahead.
